Skip to main content
OpenTrials
Completed

NCT Number: NCT02897310

Outcomes of Critically Ill Patients With Severe Acute Kidney Injury Requiring Renal Replacement Therapy

This study assess the vital status, renal function and renal recovery of patients admitted to intensive care unit and requiring renal replacement therapy for acute kidney failure. Patient follow up is up to 3 years after ICU admission when possible.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Up to 50% of critically ill patients develop acute kidney injury and up to 10% require renal replacement therapy in the intensive care unit. This study aims to identify factors associated with mortality and to evaluate renal recovery of patients who had acute kidney failure requiring renal replacement therapy in intensive care unit at 1 and 3 years post intensive care unit admission.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults admitted to the intensive care
  • Acute kidney failure requiring renal replacement therapy

Exclusion criteria

  • Patients suffering end stage renal failure requiring chronic renal replacement therapy
  • Patients under 18 years

Treatment and study plan

Primary outcomes

  1. one-year mortality

    Time frame: year 1

    vital status

Secondary outcomes

  1. hospital mortality

    Time frame: year 1

  2. one year renal function

    Time frame: Year one

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: PROVEER

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Sep 13, 2016
Registry last updated
Sep 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.